Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension

International Journal of Cardiology

Volumn 146, Issue 3, 2011, Pages 319-325

  Koh, Kwang Kon ^a   Quon, Michael J ^b   Han, Seung Hwan ^a   Lee, Yonghee ^d   Park, Jeong Beom ^a   Kim, Soo Jin ^a   Koh, Yesl ^c   Shin, Eak Kyun ^a  

^a Gachon University College of Medicine   (South Korea)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d University of Seoul   (South Korea)

Author keywords

Adiponectin; Calcium channel blocker; Endothelial function; HMG CoA reductase inhibitor; Hypertension; Insulin resistance

Indexed keywords

ADIPONECTIN; AMLODIPINE; ATORVASTATIN; INSULIN; MALONALDEHYDE; PLACEBO;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BLOOD PRESSURE; BORDERLINE HYPERTENSION; CLINICAL ARTICLE; DRUG ACTIVITY; DRUG WITHDRAWAL; FEMALE; FLUSHING; HUMAN; HYPOTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SINGLE BLIND PROCEDURE; TREATMENT DURATION;

AMLODIPINE; ANTIHYPERTENSIVE AGENTS; CROSS-OVER STUDIES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRROLES; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD;

EID: 78951488706     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.07.002     Document Type: Article

References (43)

1. J. Kim, M. Montagnani, K.K. Koh, and M.J. Quon Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms Circulation 113 2006 1888 1904
2. J. Garcia-Puig, L.M. Ruilope, M. Luque, J. Fernandez, R. Ortega, and R. Dal-Re AVANT Study Group Investigators. Glucose metabolism in patients with essential hypertension Am J Med 119 2006 318 326
3. S.H. Han, M.J. Quon, and K.K. Koh Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction Curr Op Lipidol 18 2007 58 65
4. M. Rodriguez-Porcel, L.O. Lerman, J. Herrmann, T. Sawamura, C. Napoli, and A. Lerman Hypercholesterolemia and hypertension have synergistic deleterious effects on coronary endothelial function Arterioscler Thromb Vasc Biol 23 2003 885 891
5. B. Dahlof, P.S. Sever, and N.R. Poulter et al; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial Lancet 366 2005 895 906
6. H.M. Colhoun, D.J. Betteridge, and P.N. Durrington et al; CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Lancet 364 2004 685 696
7. P.S. Sever, B. Dahlof, and N.R. Poulter et al; ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial Lancet 361 2003 1149 1158
8. Sabatine MS, Wiviott SD, Morrow DA, McCabe CH, Cannon CP; TIMI Study Group. High-dose atorvastatin associated with worse glycemic control: A PROVE-IT TIMI 22 Substudy. Circulation 2004;110:Supplement III-834 (abstract).
9. T. Yada, M. Nakata, T. Shiraishi, and M. Kakei Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signalling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet beta-cells Br J Pharmacol 126 1999 1205 1213
10. L.H. Chamberlain Inhibition of isoprenoid biosynthesis causes insulin resistance in 3 T3-L1 adipocytes FEBS Lett 507 2001 357 361
11. M. Kanda, K. Satoh, and K. Ichihara Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin Biol Pharm Bull 26 2003 1681 1684
12. G. Paolisso, M. Barbagallo, and G. Petrella Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidemic non-insulin dependent diabetic patients Atherosclerosis 150 2000 121 127
13. K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of patients with combined hyperlipidemia J Am Coll Cardiol 45 2005 1649 1653
14. K.K. Koh, M.J. Quon, and S.H. Han Simvastatin improves flow-mediated dilation, but reduces adiponectin levels and insulin sensitivity in hypercholesterolemic patients Diabetes Care 31 2008 776 782
15. M. Ohrvall, H. Lithell, J. Johansson, and B. Vessby A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia Metabolism 44 1995 212 217
16. K.K. Koh, S.H. Han, J.Y. Ahn, W.-J. Chung, Y. Lee, and E.K. Shin Amlodipine improves endothelial function and metabolic parameters in patients with hypertension Int J Cardiol 133 2009 23 31
17. K.K. Koh, S.H. Han, and M.J. Quon Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions J Am Coll Cardiol 46 2005 1978 1985
18. S.H. Han, M.J. Quon, J.A. Kim, and K.K. Koh Adiponectin and cardiovascular disease: response to therapeutic interventions J Am Coll Cardiol 49 2007 531 538
19. J.G. Yu, S. Javorschi, and A.L. Hevener The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects Diabetes 51 2002 2968 2974
20. World Health Organization International Society of Hypertension guidelines for the management of hypertension J Hypertens 17 1999 151 183
21. K.K. Koh, M.J. Quon, and S.J. Lee Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in non-diabetic patients with hypertension Diabetes Care 30 2007 1605 1607
22. K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients Circulation 110 2004 3687 3692
23. A. Katz, S.S. Nambi, and K. Mather Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
24. N. Ouchi, S. Kihara, and T. Funahashi Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 107 2003 671 674
25. K.K. Koh, M.J. Quon, and S.H. Han Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes Hypertension 45 2005 1088 1093
26. K.K. Koh, M.J. Quon, and S.H. Han Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hypertriglyceridemic hypertensive patients Diabetes Care 29 2006 195 201
27. K.K. Koh, and M.J. Quon Targeting converging therapeutic pathways to overcome hypertension Int J Cardiol 132 2009 297 299
28. K.K. Koh, P.C. Oh, and M.J. Quon Does reversal of oxidative stress and inflammation provide vascular protection? Cardiovasc Res 81 2009 649 659
29. K.K. Koh, M.J. Quon, and M.A. Waclawiw Are statins effective for simultaneously treating dyslipidemias and hypertension? Atherosclerois 196 2008 1 8
30. K.K. Koh Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability Cardiovasc Res 47 2000 648 657
31. R.P. Mason, P. Marche, and T.H. Hintze Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine Arterioscler Thromb Vasc Biol 23 2003 2155 2163
32. M.S. Zhou, E.A. Jaimes, and L. Raij Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats Am J Hypertens 17 2004 167 171
33. E.N. Taylor, F.B. Hu, and G.C. Curhan Antihypertensive medications and the risk of incident type 2 diabetes Diabetes Care 29 2006 1065 1070
34. D. Lender, C. Arauz-Pacheco, L. Breen, P. Mora-Mora, L.C. Ramirez, and P. Raskin A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients Am J Hypertens 12 1999 298 303
35. Y. Harano, A. Kageyama, and J. Hirose Improvement of insulin sensitivity for glucose metabolism with the long-acting Ca-channel blocker amlodipine in essential hypertensive subjects Metabolism 44 1995 315 319
36. P. Ferrari, D. Giachino, and P. Weidmann Unaltered insulin sensitivity during calcium channel blockade with amlodipine Eur J Clin Pharmacol 41 1991 109 113
37. M. de Courten, P. Ferrari, and M. Schneider Lack of effect of long-term amlodipine on insulin sensitivity and plasma insulin in obese patients with essential hypertension Eur J Clin Pharmacol 44 1993 457 462
38. M. Nakata, S. Nagasaka, I. Kusaka, H. Matsuoka, S. Ishibashi, and T. Yada Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control Diabetologia 49 2006 1881 1892
39. H. Chen, G. Sullivan, and M.J. Quon Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model Diabetes 54 2005 1914 1925
40. R. Muniyappa, S. Lee, H. Chen, and M.J. Quon Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage Am J Physiol Endocrinol Metab 294 2008 e15 e26
41. H. Chen, M. Montagnani, T. Funahashi, I. Shimomura, and M.J. Quon Adiponectin stimulates production of nitric oxide in vascular endothelial cells J Biol Chem 278 2003 45021 45026
42. N. Harada, M. Ohnaka, S. Sakamoto, Y. Niwa, and Y. Nakaya Cilnidipine improves insulin sensitivity in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous NIDDM Cardiovasc Drugs Ther 13 1999 519 523
43. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150